Orchestra BioMed Holdings, Inc.·4

Mar 27, 4:30 PM ET

Aiello Joshua 4

4 · Orchestra BioMed Holdings, Inc. · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Orchestra BioMed (OBIO) Principal Accounting Officer Withholds 241 Shares

What Happened
Joshua Aiello, Principal Accounting Officer of Orchestra BioMed (OBIO), had 241 shares withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units. The withholding was at $4.57 per share, totaling $1,101. This was not an open-market sale; shares were retained by the issuer to cover taxes.

Key Details

  • Transaction date: 2026-03-25; Form 4 filed: 2026-03-27 (filed within the typical two-business-day window).
  • Withheld shares: 241 at $4.57 per share, total value $1,101.
  • Shares owned after transaction: not specified in this filing.
  • Footnote: Issuer withheld shares to satisfy tax withholding on RSU vesting; no shares were sold in the market. (F1)

Context
Withholding shares to cover taxes on vested RSUs is a common, administrative disposition and does not reflect an active sell order in the market. These transactions are routine and generally less informative about an insider’s view of the company than outright open-market purchases or sales.

Insider Transaction Report

Form 4
Period: 2026-03-25
Aiello Joshua
Principal Accounting Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.0001 per share ("Common Stock")

    [F1]
    2026-03-25$4.57/sh241$1,10118,644 total
Footnotes (1)
  • [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
Signature
/s/ Andrew Taylor, Attorney-in-Fact|2026-03-27

Documents

1 file
  • 4
    tm269936-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT